• Home
  • News
  • Fortune 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
InvestingMarkets

Novo Nordisk stock trades at 4-year-low on the back of disappointing Alzheimer’s trial

Nick Lichtenberg